Amazon (NASDAQ: AMZN | AMZN Price Prediction) just made a quiet move that could reshape how Americans access weight-loss drugs. On April 9, 2026, it announced that its pharmacy unit will stock…
Amazon (NASDAQ:AMZN | AMZN Price Prediction) shares are up 5% in Thursday’s session, climbing from $221.25 to $232 as of midday. Multiple independent catalysts are landing simultaneously, each capable of moving the…
Live Updates Market Turnaround12:52pm ETThe markets have recovered earlier losses in a whipsaw trading session, with all three of the major stock market averages now in the green. The Nasdaq Composite is…
Eli Lilly (NYSE: LLY | LLY Price Prediction) and JPMorgan Chase (NYSE: JPM) both have market caps around $800 billion, putting them in a live race to a $1 trillion market cap.…
Eli Lilly (NYSE:LLY | LLY Price Prediction) has built one of the most remarkable growth stories in modern pharmaceutical history through its GLP-1 franchises. Mounjaro and Zepbound conquered the weight-loss market, giving…
One of the world’s leading healthcare names, Novo Nordisk (NYSE:NVO | NVO Price Prediction) cut prices on Wegovy and Ozempic by up to 48% in India at the start of April 2026,…
VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of betting on a single drug pipeline. Right now, that diversification is being…
Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT), a pure-play sector fund that has quietly compounded wealth for long-term investors…
The S&P 500 you own through a standard index fund is not as diversified as it looks. The cap-weighted version of the index hands roughly a third of your money to a…
Half of every dollar invested in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) rides on just two companies pulling in opposite directions in 2026. With a 0.38% expense ratio, nearly $1.1 billion in net…
NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) shares are up roughly 2% in Monday morning trading, offering a modest but welcome rebound after a rough stretch to start 2026. The stock closed Friday…
Growth investing has had a choppy start to 2026. The major growth benchmarks are down in the low single digits year-to-date, and some of the biggest names in tech have pulled back…
Building a seven-figure portfolio from scratch requires one thing above almost everything else: time in the market, compounded through funds that systematically own the companies driving the economy forward. Growth ETFs are…
Eli Lilly (NYSE:LLY | LLY Price Prediction) stock is down 5% in Tuesday afternoon trading, with shares falling to $937 from a prior close of $989.12. The move adds to a rough…
Eli Lilly (NYSE:LLY | LLY Price Prediction) shares have pulled back sharply, falling 9% over the past month, and 13% year-to-date. Most Wall Street analysts remain constructive, with a consensus price target…
Joel South 
